Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2016-08-31 17:59:08
Veloxis Pharmaceuticals A/S
Investor News
Veloxis Pharmaceuticals A/S Completes Closure of its Hørsholm, Denmark Office
Investor Service Announcement no. 5/2016
To: NASDAQ Copenhagen A/S
Copenhagen, Denmark, 31 August 2016
Veloxis Pharmaceuticals A/S Completes Closure of its Hørsholm, Denmark Office
Veloxis Pharmaceuticals A/S has completed the closure of its office in
Hørsholm, Denmark. This closure was previously announced on 9 March 2016 as
part of a company restructuring to move all activities to the United States.
The company’s registered address in Denmark will now be:
Veloxis Pharmaceuticals A/S
c/o Plesner Advokatfirma
Amerika Plads 37
2100 København Ø
For more information, please contact:
Veloxis Pharmaceuticals A/S
Craig A. Collard
President & CEO
Phone: +1 919 591 3065
Email: cac@veloxis.com
About Veloxis Pharmaceuticals
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a
commercial-stage specialty pharmaceutical company committed to improving the
lives of transplant patients. A Danish company, Veloxis Pharmaceuticals A/S
operates in the U.S. through Veloxis Pharmaceuticals Inc., a wholly-owned
subsidiary headquartered in Cary, North Carolina, USA and maintains a second
corporate office in Edison, New Jersey, USA. Veloxis has successfully
developed Envarsus XR (tacrolimus extended-release tablets) based upon the
company’s unique and patented delivery technology, MeltDose®, which is designed
to enhance the absorption and bioavailability of select orally administered
drugs. The company is focused on the direct commercialization of Envarsus XR in
the US, expansion of partnerships for markets around the world, and acquisition
of assets utilized in transplant patients and by adjacent medical specialties.
Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX:
VELO. For further information, please visit www.veloxis.com.